Disclaimer: Effective November 29, 2022, Viatris completed the sale of substantially all of its biosimilars portfolio (including related product trademarks) to Biocon Biologics Limited and its subsidiaries (“Biocon”) and the relevant marketing authorizations are in process of being transferred. Viatris Inc. and its subsidiaries (“Viatris”) are not affiliates of Biocon but are providing certain transition services to Biocon following the transaction completion date, such as operating websites (including this site) relating to the biosimilars portfolio on Biocon’s behalf.

ASHRAY- A warm & caring companion to help patients fight against cancer.

Ashray is a unique patient centric program designed to improve patient care by directly addressing some of the pressing concerns in the management of cancer.

The key area of operation includes:

1. Psychological support in the form of counselling
2. Financial support in terms of providing subsidized medication cost

Since its inception in 2014, our pioneering program ASHRAY is able to touch the lives of 5000+ patients in 500+ cities & towns, who received medication support, better patient care outside clinic and therapy compliance with periodic updates & interventions on Cancer care.

ASHRAY is managed by independent third party Medybiz Pharma Pvt Ltd which is HIPPA compliant demonstrating its compliance with IS/ISO/IEC 27001 standards and thus maintains highest levels of protection for personal data.